Related Experiment Videos
Huge skin tumor diffuse large cell lymphoma associated with essential thrombocytosis
T Fujiwara1, K Kojima, F Ishimaru
1The Second Department of Medicine, Okayama University Medical School.
Internal Medicine (Tokyo, Japan)
|August 24, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Acute lymphoblastic leukemia with large molecular ACTH production.
Annals of hematology·2003
Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2002
[An adult patient with varicella preceded by acute thrombocytopenia].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2002
Therapy-related myelodysplastic syndrome/acute myeloid leukemia M2 and translocation (8;21).
Annals of hematology·2002
Diagnostic Tissue Re-Evaluation Supporting the Observation of a 11C-Methionine PET-Negative Residual Paraskeletal Mass in Multiple Myeloma.
Internal medicine (Tokyo, Japan)·2026
Late-onset Human Herpesvirus 6 Encephalitis with Secondary Hemophagocytic Lymphohistiocytosis after CAR T-cell Therapy.
Internal medicine (Tokyo, Japan)·2026
A Case of Pancreaticobiliary Maljunction Associated with IgG4-related Sclerosing Cholangitis and Type 1 Autoimmune Pancreatitis.
Internal medicine (Tokyo, Japan)·2026
Advances in γδ T Cells: Cutaneous Biology and Therapeutic Potential for Skin Neoplasms.
The Journal of dermatology·2026
Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.
Apoptosis : an international journal on programmed cell death·2026
Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.
Frontiers in oncology·2026
Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.
Nature reviews. Cancer·2026
Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.
Clinical rheumatology·2026